HomeCompareLBTSF vs STAG

LBTSF vs STAG: Dividend Comparison 2026

LBTSF yields 1.34% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LBTSF wins by $12.87M in total portfolio value
10 years
LBTSF
LBTSF
● Live price
1.34%
Share price
$15.35
Annual div
$0.21
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.89M
Annual income
$11,275,798.89
Full LBTSF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — LBTSF vs STAG

📍 LBTSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBTSFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBTSF + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBTSF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBTSF
Annual income on $10K today (after 15% tax)
$114.07/yr
After 10yr DRIP, annual income (after tax)
$9,584,429.06/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, LBTSF beats the other by $9,584,036.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBTSF + STAG for your $10,000?

LBTSF: 50%STAG: 50%
100% STAG50/50100% LBTSF
Portfolio after 10yr
$6.45M
Annual income
$5,638,130.55/yr
Blended yield
87.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

LBTSF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.0
Piotroski
7/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBTSF buys
0
STAG buys
0
No recent congressional trades found for LBTSF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBTSFSTAG
Forward yield1.34%3.44%
Annual dividend / share$0.21$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0.3%
Portfolio after 10y$12.89M$18.3K
Annual income after 10y$11,275,798.89$462.22
Total dividends collected$12.74M$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: LBTSF vs STAG ($10,000, DRIP)

YearLBTSF PortfolioLBTSF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$10,968$268.40$10,665$345.09+$303.00LBTSF
2$12,286$550.27$11,364$357.70+$922.00LBTSF
3$14,299$1,152.15$12,098$370.43+$2.2KLBTSF
4$17,806$2,506.24$12,869$383.28+$4.9KLBTSF
5$24,886$5,833.59$13,677$396.23+$11.2KLBTSF
6$41,867$15,239.53$14,524$409.27+$27.3KLBTSF
7$92,721$47,922.73$15,411$422.41+$77.3KLBTSF
8$297,587$198,376.17$16,339$435.61+$281.2KLBTSF
9$1,508,490$1,190,071.76$17,311$448.89+$1.49MLBTSF
10$12,889,884$11,275,798.89$18,327$462.22+$12.87MLBTSF

LBTSF vs STAG: Complete Analysis 2026

LBTSFStock

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous system; alimentary tract and metabolism; antiinfectives for systemic use; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. Its products include Ilumetri, Solaraze, Actikerall, Ciclopoli, Skilarence, Aczone, Decoderm, Cordran Tape, Azelex, Klisyri, Tazorac, Seysara, Veltin, Almax, Ebastel, Sativex, Crestor, and Efficib/Tesavel. Almirall, S.A. has collaboration and partnership agreements with Tyris Therapeutics, BIOMAP, the University of Dundee, Kaken Pharmaceutical Co Ltd., Ichnos Sciences Inc., the University Carlos III Madrid and MEDINA Foundation, 23andMe, Inc., HitGen Ltd., WuXi Biologics, Eli Lilly and Company, and Athenex, Inc. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Full LBTSF Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this LBTSF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBTSF vs SCHDLBTSF vs JEPILBTSF vs OLBTSF vs KOLBTSF vs MAINLBTSF vs PLDLBTSF vs EQRLBTSF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.